Insights Trading News

Get the latest markets news from our financial experts. Discussing how economic developments, trade deals, company reports, and other events impact the markets, our insights give you unique insight into your trades. 

Trading news is one of the best ways for you to stay informed about the markets you trade, so you never miss an opportunity.

Latest Insights

Tue, 5 May 2020

Morning Note

Euro wobbles ahead of German court ruling, risk appetite improves

Attention this morning was on the German constitutional court and its ruling on the ECB’s long-standing bond buying programme. This could limit the amount of bonds the Bundesbank can buy, potentially creating a rift with the ECB and other member states. The real concern is whether it could affect the €750bn Pandemic Emergency Purchase Programme (PEPP), which has much looser rules than other QE programmes. It’s high stakes – if the court blocks the Bundesbank from participating in QE it would be curtains for the ECB and creates significant Eurozone breakup risks.

Written By:
Neil Wilson

Mon, 4 May 2020

Equities

Where next for TSLA after Musk’s ‘price is too high’ tweet?

Telsa CEO Elon Musk wiped $14 billion off the value of his own company on May 1st after tweeting that he thought the stock price was “too high”. Has he landed himself in hot water with the SEC again, and what could this mean for traders and investors holding Tesla stock?

Written By:
Rewan Tremethick

Mon, 4 May 2020

Morning Note

European markets tumble in catchup trade, Trump bashes China

On the plus side, the UK is sketching out how it plans to end the lockdown. On the minus side, it’s going to take a long time to get back to normal. This, in a nutshell, is the problem facing the global economy and it is one reason why equity markets are not finding a straight line back to where they were pre-crisis.

Written By:
Neil Wilson

Sun, 3 May 2020

Week Ahead

Week Ahead: RBA and BoE, Disney Earnings, US NFP

Expect policy decisions from the RBA and BoE, a host more earnings reports, the US nonmanufacturing PMI, and of course the highly anticipated/dreaded April nonfarm payrolls report. Read on to see how these key events could affect the markets in the week ahead.

Written By:
Rewan Tremethick

Fri, 1 May 2020

Morning Note

FTSE 100 completes 400pt round trip this week

Stocks turned broadly weaker yesterday as investors reacted to some stinky data from Europe and the US. Overnight Asian data has also had the whiff of soft cheese that’s been left out too long. Stocks are softer once more, though most of Europe is on holiday so the focus is on London until New York opens.

Written By:
Neil Wilson

Thu, 30 Apr 2020

Equities

Wall St opens weaker on hangover for risk assets

Yesterday’s risk party has left participants with a bit of a hangover: risk assets have taken a bit of a beating today amid a slew of pretty rotten economic data and an ECB presser that maybe wasn’t all that. There is also a sense that equity markets rode too aggressively on the Gilead news and need to see more evidence, whilst the FTSE has notably underperformed thanks to the oil majors.

Written By:
Neil Wilson

Thu, 30 Apr 2020

Morning Note

Shell sold, Lloyds crumples, markets look to future post Covid

Shares in Shell slumped 7% as it cut its dividend and reported net income in the first quarter almost halved. Whilst BP chose to absorb a $6bn rise in net debt to $51bn and gearing above 36x in order to preserve its precious dividend, Shell seems to be taking a more prudent approach in cutting its dividend for the first time since the 1940s. Arguably BP is better placed to weather the storm, but Shell is taking the more sensible course of action. Shell’s gearing ratio is down to around 28x, a more comfortable level for Ben van Beurden than it is for Bernard Looney. This poses a simple question for investors – can BP keep it up? 

Written By:
Neil Wilson

Wed, 29 Apr 2020

Equities

Markets jump on Gilead news

European stocks added to gains and US futures extended higher after a report indicated positive results from Gilead’s drug trials for treating Covid-19. Meanwhile, after some delay and an initial misprint we learned US GDP contracted 4.8% in the first quarter.

Written By:
Neil Wilson

Wed, 29 Apr 2020

Morning Note

Barclays shares pop, SPX faces big hurdle with Fed, GDP ahead

Barclays CEO Jes Staley reckons that after Covid-19 the idea of sticking thousands of people in a building may be a thing of the past. I heartily agree. Working from home is clearly working rather well. Also, banks are no doubt looking at this and thinking they can cut costs by closing offices, call centres and branches. Nevertheless, it highlights how bosses and government have a very hard task in exiting lockdown. Moreover, what about the Pret or the pub that depends on lunch trade from the City workers filling up these offices every day? The impact on the economy will be permanent.

Written By:
Neil Wilson

Disclaimer: The Analyst Recommendation and Tools & Analysis services and its content should not be construed as a solicitation to invest and/or trade. There are potential risks relating to investing and trading. You should always consider your trading objectives & risk capital, you should not trade with money that you cannot afford to lose. MARKETS.COM and their associates, do not guarantee the completeness, accuracy or timeliness of the information supplied, and they shall not be liable for any loss or damages, consequential or otherwise, which may arise from the use of such services and their content. Past performance is not indicative of future performance. All opinions, news, research, analysis, prices or other information is provided as general market commentary and not as investment advice and all potential results discussed are not guaranteed to be achieved.

CySEC (EU)

  • Client’s funds are kept in segregated bank accounts
  • FSCS Investor Compensation up to EUR20,000
  • Negative Balance Protection

Products

  • CFD
  • Share Dealing
  • Quantranks

Markets.com, operated by Safecap Investments Limited (“Safecap”) Regulated by CySEC under License no. 092/08 and FSCA under Licence no. 43906.

FSC (GLOBAL)

  • Clients’ funds kept in segregated bank accounts
  • Electronic Verification
  • Negative Balance Protection

Products

  • CFD
  • Strategy Builder

Markets.com, operated by TradeTech Markets (BVI) Limited (“TTMBVI”) Regulated by the BVI Financial Services Commission (‘FSC’) under licence no. SIBA/L/14/1067.

FCA (UK)

  • Client’s funds are kept in segregated bank accounts
  • FSCS Investor Compensation up to GBP85,000
    *depending on criteria and eligibility
  • Negative Balance Protection

Products

  • CFD
  • Spread Bets
  • Strategy Builder

Markets.com operated by TradeTech Alpha Limited (“TTA”) Regulated by the Financial Conduct Authority (“FCA”) under licence number 607305.

ASIC (AU)

  • Clients’ funds kept in segregated bank accounts
  • Electronic Verification
  • Negative Balance Protection

Products

  • CFD

Markets.com, operated by Tradetech Markets (Australia) Pty Limited (‘TTMAU”) Holds Australian Financial Services Licence no. 424008 and is regulated in the provision of financial services by the Australian Securities and Investments Commission (“ASIC”).

FSCA (ZA)

  • Clients’ funds kept in segregated bank accounts
  • Negative Balance Protection

Products

  • CFD
  • Strategy Builder

Markets.com, operated by TradeTech Markets (South Africa) (Pty) Limited (“TTMSA”) Regulated by Financial Sector Conduct Authority (‘FSCA’) under the licence no. 46860.

Selecting one of these regulators will display the corresponding information across the entire website. If you would like to display information for a different regulator, please select it. For more information click here.

Marketsi
An individual approach to investing.

Whether you’re investing for the long-term, medium-term or even short-term, Marketsi puts you in control. You can take a traditional approach or be creative with our innovative Investment Strategy Builder tool, our industry-leading platform and personalised, VIP service will help you make the most of the global markets without the need for intermediaries.

Share Dealing in the Markets Group is only offered by Safecap Investments Limited regulated by CySEC under license number 092/08. We are now re-directing you to Safecap’s website.

Redirect